RNU6-965P

Across TCGA pan-cancer cohorts, RNU6-965P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU6-965P data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RNU6-965P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-965P expression acts as an unfavorable survival marker.

STAD, ESCA, and KIRC are the cancer types where RNU6-965P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.052	0.496	<.001	90	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
KIRC	DFS	Tertile	IV	0.204	0.623	.011	36	view →
BRCA	OS	Tertile	All	0.102	0.578	.025	36	view →
GBM	DFS	Tertile	All	0.052	0.257	.002	18	view →
SARC	DFS	Tertile	All	0.207	0.612	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU6-965P–STAD (OS)

Open the STAD breakdown →